Clinical trials recruiting for Overweight or Obesity

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of BGM0504 Injection in Participants with Obesity or Overweight
  NCT06704581 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants
  NCT07294235 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study of HS-20094 in Overweight or Obese Participants
  NCT07057674 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
  NCT07575932 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 65 locations
• A Study to Evaluate MWN109 Tablets in Healthy Adult Participants
  NCT06938269 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
  NCT06864026 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 55 locations
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 39 locations
• Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health
  NCT06953232 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 75 Years · Sex: Female · 1 location
• Better Lifestyle Counseling for African American Women During Pregnancy
  NCT05234125 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: Female · 2 locations
• Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
  NCT06596265 · Phase: Not specified · Ages: 12 Years to 17 Years · Sex: All (male and female) · 3 locations
• Craving Network Neurofeedback
  NCT06426693 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
  NCT07376655 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 152 locations
• Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
  NCT07292441 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Healthy Living BEYOND Weight Study
  NCT07075341 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lifestyle Intervention in Overweight/Obese Chronic Low Back Pain (CLBP) Patients: an International Multi-center RCT
  NCT05811624 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Metformin as Adjunct Therapy in Depression-obesity Comorbidity: Clinical and Genetic Evaluation
  NCT07654179 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 4 locations
• NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
  NCT05674799 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 39 Years · Sex: Female · 1 location
• Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
  NCT04228978 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects
  NCT07150962 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
  NCT07594093 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
  NCT06499857 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
  NCT07685808 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
  NCT05770570 · Phase: Phase 2 · Ages: 21 Years and older · Sex: All (male and female) · 1 location
• Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
  NCT07708064 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• The Acute T-Rex (Timing of Resistance Exercise) Study
  NCT06366399 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 74 Years · Sex: All (male and female) · 2 locations
• The Effects of Remimazolam on the Incidence of Severe Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients
  NCT06187896 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 50 Years · Sex: Female · 1 location
• The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
  NCT06606821 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment
  NCT07395960 · Phase: Phase 1, Phase 2 · Ages: 60 Years to 75 Years · Sex: All (male and female) · 1 location
• The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
  NCT06830343 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Weight Reduction in CLBP
  NCT04824248 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• eMOTION: Examining Affective Mechanisms in Physical Activity Engagement
  NCT06570642 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• eMOTION: Examining Implicit Attitudes in Physical Activity Engagement
  NCT07044570 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Overweight or Obesity often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Overweight or Obesity trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.